eCARTv5 Clinical Deterioration Suite (eCART) vs VisualDx

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

VisualDx

by VisualDx

AI Verdict

Both AgileMD's eCARTv5 and VisualDx are AI-powered clinical decision support systems, making them adjacent competitors. However, eCARTv5 focuses on predicting clinical deterioration in hospitalized patients, while VisualDx specializes in diagnostic accuracy, particularly in dermatology, leveraging an extensive image library. The choice between them depends on whether the primary need is proactive risk assessment for critical care or enhanced diagnostic support for a broader range of conditions, especially visual ones.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary concern is proactively identifying and managing the risk of clinical deterioration in hospitalized adult patients. This tool is ideal for hospitals and critical care units seeking an AI-powered early warning system that integrates with EHRs to provide continuous risk assessment and guide care with embedded clinical pathways, ultimately aiming to reduce ICU transfers and mortality. It's particularly well-suited for environments where minimizing false alarms and clinician workload while maximizing early intervention is crucial.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose VisualDx if…

Choose VisualDx if your focus is on enhancing diagnostic accuracy, particularly in dermatology, and addressing health inequities through visual clinical decision support. This tool is best for individual clinicians, hospitals, and health systems that require an extensive medical image library, AI-powered differential diagnosis builder, and patient education resources. It's especially valuable for specialties like dermatology, family medicine, and internal medicine where visual cues are critical for accurate diagnosis and treatment planning.

View VisualDx →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	VisualDx
Pricing	Contact vendor	Paid-subscription
Deployment	SaaS (Software as a Service).	Cloud-based, on-premise-offline-version-available
FDA Status	1 AI-estimated	Exempt AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize user-friendly interfaces and seamless integration into clinical workflows. VisualDx highlights its intuitive design, mobile accessibility, and recent updates for smoother navigation and faster differential building. AgileMD's eCARTv5 is also noted for its user-friendly design, real-time data display within the EHR, and customizable alerts, suggesting a strong focus on practical usability for clinicians.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 focuses on continuous, real-time prediction of clinical deterioration (death or ICU transfer) using up to 97 variables, directly integrating with EHRs to guide care with embedded clinical pathways. This directly addresses critical, time-sensitive patient outcomes across general hospitalized adult patients. VisualDx, while highly valuable for diagnostic accuracy, particularly in dermatology, serves as a decision support and reference tool rather than a continuous predictive early warning system for acute deterioration across multiple specialties.

Pricing & Value

VisualDx

VisualDx offers transparent individual subscription pricing with different tiers (Core, Elite, VisualDx Plus DermExpert) and a free trial, making it accessible for individual clinicians and smaller practices. AgileMD's eCARTv5 requires contacting the vendor for a tailored quote, which, while common for enterprise solutions, lacks the upfront transparency of VisualDx for individual users or smaller-scale adoption.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. AgileMD's eCARTv5 is designed for seamless EHR integration, is HIPAA compliant, and has been deployed at numerous hospitals, with a focus on rapid implementation and robust security. VisualDx also emphasizes its enterprise-ready platform, secure architecture (HIPAA-aligned, SOC 2), EHR integrations (HL7, FHIR, SMART on FHIR), and support for large-scale deployments across health systems.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 stands out with its FDA-cleared, AI-powered Software as a Medical Device (SaMD) that provides continuous, real-time predictive analytics for clinical deterioration, integrating directly into EHRs to trigger clinical pathways. This represents a significant innovation in proactive patient management and early intervention. While VisualDx utilizes AI for diagnostic support and has an extensive image library, its core function as a visual diagnostic aid is a more established application of AI in healthcare.

Support & Docs

VisualDx

VisualDx offers a comprehensive support system including video tutorials, an extensive FAQ section, a customer support form, and developer documentation for its API. AgileMD's documentation and support details are less explicitly outlined in the provided information, although it does mention reporting and benchmarking capabilities and collaboration with IT teams for security frameworks.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	VisualDx
Name	eCARTv5 Clinical Deterioration Suite (u0093eCARTu0094)	VisualDx
Company	AgileMD	VisualDx
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Award-winning AI-powered clinical decision support system, renowned for its strength in dermatology, that enhances diagnostic accuracy and aids therapeutic decisions for individual clinicians, hospitals, and health systems globally. It features an extensive image library and AI tools to improve patient care and combat health inequities.
Primary Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Dermatology, Family Medicine, Internal Medicine
Key Features (Examples)	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables)	AI for Dermatology (DermExpert), Visual Clinical Decision Support, Extensive Medical Image Library (over 46,000 images)

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and VisualDx.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply do these tools integrate with existing EHR systems and clinical workflows?

eCARTv5 is designed for deep EHR integration, utilizing up to 97 real-time variables from the EHR to continuously assess patient risk and guide care with embedded clinical pathways. VisualDx also offers EHR integrations, including HL7, FHIR, and SMART on FHIR, allowing clinicians to access it directly from the patient chart and reducing the need for tool switching during patient encounters.

What is the proven accuracy and sensitivity of each tool in its respective clinical domain?

eCARTv5 has demonstrated high accuracy in predicting clinical deterioration, with an AUROC of 0.834 in retrospective validation and consistent performance across diverse patient demographics and conditions. VisualDx has been shown to improve diagnostic accuracy by 34% among primary care doctors for skin conditions, with its DermExpert AI achieving 68% accuracy in analyzing skin conditions, comparable to PCPs using a visual aid.

What is the typical learning curve for physicians to become proficient with each tool?

VisualDx is designed for speed and ease of use, with integrations and smart filters to reduce time spent looking for information. One study indicated a 120% increase in accurate diagnosis for non-dermatologists with just four minutes of training on VisualDx. Information on the specific learning curve for eCARTv5 is not explicitly detailed, but its integration with existing EHRs and clinical pathways suggests a focus on fitting into current workflows.

What kind of customer support and resources are available to optimize tool utilization and address issues?

VisualDx provides dedicated support staff, video tutorials, and an expanding FAQ section to help customers. They also offer implementation teams to help organizations tailor the experience to fit clinician workflows. For eCARTv5, while specific support details are not listed, its nature as an FDA-cleared SaMD implies a level of support for clinical use.

What audit-trail features are available to track usage, decisions, and patient outcomes related to the tool's recommendations?

VisualDx offers usage and reporting features to help understand adoption and usage patterns, which can support training, rollout improvements, and value demonstration. For security, VisualDx states it only reads data via standard FHIR endpoints and does not store or change any personal health information, with the EHR responsible for data integrity. eCARTv5 is integrated into the EHR and calculates risk from validated EHR data, but specific audit-trail features are not detailed.

How do these tools support multi-site rollout and ensure consistent performance across different clinical environments?

VisualDx is built for enterprise healthcare, supporting organizations that require scale, security, and reliability, and can adapt to different environments for system-wide decision support. Its implementation team assists organizations in tailoring the experience to fit clinician workflows across sites. eCARTv5 has been validated retrospectively in a geographically diverse set of health systems and prospectively across 21 hospitals from three health systems, suggesting its suitability for multi-site deployment with consistent performance.

Beyond HIPAA, what additional security measures are in place to protect patient data and ensure system integrity?

VisualDx has successfully completed a SOC 2 examination, affirming its infrastructure, software, people, data, policies, procedures, and operations meet security criteria. It also states that for its AI image analysis, no patient-identifiable information is collected, images are not stored or transmitted, and no data is linked to individual patients. eCARTv5 is integrated into the EHR and calculates risk from validated EHR data, and as a cloud-based SaaS, it would adhere to robust cloud security practices.